Rezultate preliminare PCCA 2011/2012 Proiecte de tip 2 DC 4 - Sănătate Nume Prenume Nr. Cod director de director Titlu proiect Institutie coordonatoare Punctaj Crt depunere proiect de proiect PN-II-PT-PCCA- IMAGE AND ELECTROMAGNETIC GUIDED INNOVATIVE 1 Lucian Gruionu MEDINSYS 91.67 2011-3.2-0482 SYSTEM FOR TRANSBRONCHIAL BIOPSY National Institute of Research and PN-II-PT-PCCA- Investigation of viral and host markers of non-response to 2 Oprisan Gabriela Rodica Development in Microbiology and 90.25 2011-3.2-1150 anti-viral treatment in chronic hepatitis C Immunology “Cantacuzino" GENOMEWIDE STUDY OF BIPOLAR I DISORDER AND PN-II-PT-PCCA- SPITALUL CLINIC DE PSIHIATRIE PROF DR. 3 Serbanescu Maria GUIDE FOR ASSESSING THE GENETIC RISK FOR BIPOLAR I 90.00 2011-3.2-1628 ALEXANDRU OBREGIA DISORDER IN THE ROMANIAN POPULATION PN-II-PT-PCCA- Role of S100A4 and MAP4K4 in pancreatic ductal 4 popescu irinel FUNDENI CLINICAL INSTITUTE 88.33 2011-3.2-1490 adenocarcinoma progression PN-II-PT-PCCA- Real Time quantitative PCR evaluation of differentiation, National Institute of Research and Diagnosis 5 Giovanni Bussolati 87.33 2011-3.2-0623 drug sensitivity and prognosis of endocrine tumors. Victor Babes PN-II-PT-PCCA- Advanced strategies for high performance indoor Universitatea Tehnica de Constructii 6 Nastase Ilinca 87.00 2011-3.2-1212 Environmental QUAliTy in Operating Rooms Bucuresti PROTEOMICS AND METABOLOMICS IN DIAGNOSIS AND PN-II-PT-PCCA- 7 VOICULESCU MIHAI SCORING OF VASCULAR CALCIFICATIONS IN CHRONIC INSTITUTUL CLINIC FUNDENI 86.25 2011-3.2-0794 RENAL FAILURE Novel nanostructured prosthetic tubular devices with PN-II-PT-PCCA- 8 Ficai Anton antibacterial and antibiofilm properties induced by physico- University Politehnica of Bucharest 86.00 2011-3.2-0284 chemical and morphological changes Development and preclinical evaluation of nanoparticulate PN-II-PT-PCCA- Universitatea de Medicina si Farmacie ”Iuliu 9 Vlase Laurian drug delivery systems for targeted antitumor therapy of 85.33 2011-3.2-1060 Hatieganu” colorectal cancer Page 1 of 6 Nume Prenume Nr. Cod director de director Titlu proiect Institutie coordonatoare Punctaj Crt depunere proiect de proiect Analysis of microRNA biomarkers as predictive values for PN-II-PT-PCCA- 10 Balacescu Ovidiu cervical cancer treatment, in relationship with The Oncology Institute „Prof.Dr.I.Chiricuta” 85.00 2011-3.2-1328 environmental exposure to arsenic, phthalates and ETS. Validation of siRNA technology for the silencing of microglial PN-II-PT-PCCA- 11 Ristoiu Violeta Paula targets significant for neuropathic pain and Alzheimer University of Bucharest 84.67 2011-3.2-0086 disease BIOMARKER PANEL DESIGN FOR INDIVIDUALIZED PN-II-PT-PCCA- PREDICTION OF THE THERAPEUTIC RESPONSE IN 12 Baicus Cristian Spitalul Clinic Colentina 84.00 2011-3.2-0221 CHRONIC HEPATITIS C, BASED ON AN INTEGRATED BIOINFORMATICS APPROACH PN-II-PT-PCCA- Coagulation disorders in subclinical hypothyroidism. Clinical 13 Dermengiu Dan National Institute of Legal Medicine 83.25 2011-3.2-0500 and medical-legal consequences PN-II-PT-PCCA- New biodegradable scaffold materials for bone 14 Furtos Gabriel Babes Bolyai University, Cluj-Napoca 83.25 2011-3.2-1654 reconstruction Study of pathogenicity and virulence markers of influenza “Cantacuzino” National Institute for PN-II-PT-PCCA- virus in adults and children with severe acute respiratory 15 Radu Dorel Research and Development in Microbiology 82.67 2011-3.2-0677 infection, correlated with immune host response and clinical and Immunology evolution Neurogenic detrusor overactivity treated with Botulinum PN-II-PT-PCCA- 16 Antochi Florina Anca Toxin A (BTX-A) and Neuromodulation, urodynamic and Fundatia "Prof.Dr.Dimitrie Gerota" 82.67 2011-3.2-1241 quality of life PN-II-PT-PCCA- Development of a New Screening Tool for Viral and Universitatea de Medicina si Farmacie “Carol 17 Mischianu Dan Liviu Dorel 82.33 2011-3.2-0933 Molecular Markers in Prostate Cancer Davila” PN-II-PT-PCCA- Production and characterization of phytomolecules with 18 Cucu Daniela Universitatea din Bucuresti 82.00 2011-3.2-0201 antiviral activity against hepatitis B and C viruses PN-II-PT-PCCA- 19 PETRESCU Barbu-Serban BRAIN AND ELECTROSTIMULATION INDUCED MOVEMENT S.C. NEURON GROUP SRL 81.75 2011-3.2-1265 Implementation of a complex genome profiling diagnostic PN-II-PT-PCCA- 20 Diaconu Carmen Cristina algorithm for patients with congenital and developmental Stefan S. Nicolau Institute of Virology 81.50 2011-3.2-1675 abnormalities EVALUATION OF DRUGS AND NANOSTRUCTURED DRUG PN-II-PT-PCCA- SYSTEMS EFFECTS ON PLATELET AND ERYTHROCYTE Universitatea de Medicina si Farmacie "Carol 21 MIRCIOIU CONSTANTIN 80.75 2011-3.2-1773 AGGREGATION FOR INDIVIDUALIZATION OF Davila" Bucuresti ANTIAGGREGANT THERAPY PN-II-PT-PCCA- New fibre-reinforced composite materials for custom-made Iuliu Hatieganu University of Medicine and 22 Rotaru Horatiu 80.25 2011-3.2-0308 craniofacial implants fabrication Pharmacy Page 2 of 6 Nume Prenume Nr. Cod director de director Titlu proiect Institutie coordonatoare Punctaj Crt depunere proiect de proiect INTEGRATING SNP PROFILING OF PROSTATE AND PN-II-PT-PCCA- Universitatea de Medicina si Farmacie "Carol 23 Viorel Jinga COLORECTAL CANCER INTO PREDICTIVE MODELS OF 80.00 2011-3.2-1273 Davila" CLINICAL UTILITY Development of magnetic resonance imaging methods to PN-II-PT-PCCA- 24 Andronesi Ovidiu obtain endophenotypes for bio-psychological vulnerability in Universitatea Babes Bolyai 80.00 2011-3.2-1673 mental illnesses - application to major depressive disorder New therapies using hydrogels with Thuja occidentalis PN-II-PT-PCCA- Universitatea de Medicina si Farmacie 25 Costuleanu Marcel extracts for modulating the induced pluripotent stem cells 79.33 2011-3.2-1768 "Grigore T. Popa" Iasi (iPSC) in dermal wound healing Interdisciplinary Platform Based on the Intercorelation of PN-II-PT-PCCA- the Neuroadaptative and Integrative Mechanisms in the University of Medicine and Pharmacy Carol 26 Ovidiu-Alexandru Bajenaru 79.25 2011-3.2-1403 Rehabilitation of Loss of Speech and Language Abilities in Davila Neurological Patients National Research and Development PN-II-PT-PCCA- NANOG Pathways- new biomarkers in the diagnosis and 27 Carmen Maria Ardeleanu Institute in the Field of Pathology and 78.33 2011-3.2-1099 personalised therapy monitoring of the esogastric cancer Biomedical Sciences Victor Babes Biowaiving safety and efficacy evaluations for rectal PN-II-PT-PCCA- University of Medicine and Pharmacy Carol 28 Lupuleasa Dumitru semisolid dosage forms based on biorelevant in vitro 78.00 2011-3.2-1197 Davila Bucharest methodology PN-II-PT-PCCA- Protocol for diagnosis and parasitic therapy of inflammatory University of Medicine and Pharmacy Iuliu 29 Dumitrascu Dan Lucian 77.67 2011-3.2-1256 bowel disease based on biopreparation with Trichuris suis. Hatieganu Cluj-Napoca, Romania PN-II-PT-PCCA- INDOOR EXPOSURE TO MIXTURES AND BRONCHIAL S.C. CENTRUL DE MEDIU SI SANATATE 30 Gurzau Eugen Stelian 77.00 2011-3.2-0226 ASTHMA S.R.L. PN-II-PT-PCCA- New molecular kit and cryo-media for human amniotic fluid Institute of Cellular Biology and Pathology 31 Maniu Horia 76.67 2011-3.2-1079 alternative stem cell storage "Nicolae Simionescu" Study of molecular and genetic mechanisms of leukemic PN-II-PT-PCCA- transformation in myelodysplastic and Universitatea de Medicina si Farmacie "Carol 32 Vladareanu Ana-Maria 76.67 2011-3.2-1802 myelodysplastic/myeloproliferative neoplasms - predictive Davila"Bucuresti biomarkers and novel therapeutical strategies PN-II-PT-PCCA- Magnetic biomimetic scaffolds as alternative strategy for University of Medicine and Pharmacy 33 Verestiuc Liliana 76.50 2011-3.2-1589 bone tissue repair and engineering "Grigore T Popa" Iasi DEVELOPING AND STANDARDIZATION OF MODERN THERAPIES FOR DEGENERATIVE AND NEOPLASIC PN-II-PT-PCCA- Octavian 34 Unc DESEASES BY USING NOVEL BIO-NANO-PHARMACEUTICAL Sc Medical Analysis 75.75 2011-3.2-1420 Dumitru FORMULATIONS BASED ON CHEMICAL AND CELLULAR SUPPORT Page 3 of 6 Nume Prenume Nr. Cod director de director Titlu proiect Institutie coordonatoare Punctaj Crt depunere proiect de proiect “RESEARCH IN MOLECULAR EPIDEMIOLOGY AREA TO PN-II-PT-PCCA- National Institute of Infectious Diseases 35 Hristea Adriana IMPROVE INFECTION PREVENTION AND CONTROL OF 75.67 2011-3.2-1565 "Prof. Dr. Matei Bals" MULTI-DRUG-RESISTANT GRAM NEGATIVE BACILLI” PN-II-PT-PCCA- Carmen Standardization of a new technology for the production of National Institute for Lasers, Plasma and 36 Surdu-Bob 75.50 2011-3.2-1634 CRISTINA engineered implants for skin cancer therapy Radiation Physics PN-II-PT-PCCA- New PCR-based assays for the rapid detection of resistant 37 Chifiriuc Mariana Carmen University of Bucharest 75.33 2011-3.2-1148 microorganisms in clinical specimens PN-II-PT-PCCA- A new paradigm of neurocognitive and neuropsychological University of Medicine and Pharmacy "Carol 38 Dulamea Adriana 74.75 2011-3.2-1800 investigation of the man - built environment relationship Davila" GENOTYPIC AND PHENOTYPIC PROFILE OF CANCEROUS PN-II-PT-PCCA- UNIVERSITATEA DE MEDICINA SI FARMACIE 39 GEORGESCU ION CELL IN PROGRESSION AND EVOLUTION OF COLORECTAL 74.67 2011-3.2-1676 DIN CRAIOVA CARCINOMA Probabilistic model of embryo-fetal alterations induced by PN-II-PT-PCCA- 40 Vladareanu Radu maternal hematological pathology during pregnancy. Spitalul Universitar de Urgenta Elias 74.67 2011-3.2-1554 Implication of the genetic factor. PN-II-PT-PCCA- The formulation - biological barrier interplay in optimizing University of Medicine and